We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Samsung

Develops, manufactures, and markets diagnostic products and solutions for IVD and point-of-care applications read more Featured Products: More products

Download Mobile App




Adding DWI to Conventional MRI Improves Detection of Locally Recurrent Pancreatic Cancer

By MedImaging International staff writers
Posted on 26 May 2022
Print article
Image: DWI for detection of locally recurrent pancreatic cancer (Photo courtesy of Pexels)
Image: DWI for detection of locally recurrent pancreatic cancer (Photo courtesy of Pexels)

A new study has found that adding diffusion-weighted MRI (DWI) to conventional MRI improves the differentiation of locally recurrent tumor and post-surgical fibrosis after pancreatic ductal adenocarcinoma (PDAC) resection, primarily due to improved sensitivity for recurrence.

The retrospective study by researchers at Samsung Medical Center (Seoul, Korea) included 66 patients (35 men, 31 women; mean age, 60.5 years) with PDAC resection between January 2009 and March 2016, who underwent postoperative surveillance CT demonstrating a soft tissue lesion at the operative site or at the site of peripancreatic vessels and subsequent MRI with DWI for further evaluation. CT at least six months after MRI served as reference standard, with increase in size of the soft tissue by ≥5 mm differentiating locally recurrent tumor (n=26) and post-surgical fibrosis (n=40).

Two observers independently reviewed MRI examinations in separate sessions: conventional MRI alone vs. MRI with DWI. Compared with MRI alone, MRI and DWI showed higher sensitivity (observer 1: 88.5% vs. 61.5%, p=.008; observer 2: 84.6% vs. 42.3%, p= .001) without difference in specificity (observer 1: 72.5% vs. 80.0%, p=.08; observer 2, 95.0% vs. 85.0%, p=.10) in detecting local recurrence after PDAC resection.

“The findings indicate a potential role for MRI with DWI in surveillance protocols after PDAC resection,” said Tae Wook Kang, MD from Samsung Medical Center.

“MRI with DWI as a problem-solving tool during post-operative surveillance after PDAC resection could facilitate earlier detection of recurrences,” stated the researchers and added, “guiding prognostic assessment and treatment decisions.”

Related Links:
Samsung Medical Center 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Needle Guide
Ultra-Pro II
New
Portable X-Ray Unit
AJEX240H
New
PACS Workstation
CHILI Web Viewer

Print article

Channels

Ultrasound

view channel
Image: Structure of the proposed transparent ultrasound transducer and its optical transmittance (Photo courtesy of POSTECH)

Ultrasensitive Broadband Transparent Ultrasound Transducer Enhances Medical Diagnosis

The ultrasound-photoacoustic dual-modal imaging system combines molecular imaging contrast with ultrasound imaging. It can display molecular and structural details inside the body in real time without... Read more

Nuclear Medicine

view channel
Image: PET/CT of a 60-year-old male patient with clinical suspicion of lung cancer (Photo courtesy of EJNMMI Physics)

Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times

F-18 FDG-PET scans are a way to look inside the body using a special dye, and these scans can be either static or dynamic. Static scans happen 60 minutes after the dye is administered into the body, showing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.